← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...
HomeStocksCAMPPrice Target
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

CAMP4 Therapeutics Corporation (CAMP) Price Target Analysis

Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026

Current Price
$4.49
Market reference
Price Target
$7.00
+55.9% Upside
Target Range
$7.00 — $7.00
High conviction
Analyst Rating
Buy
23 analysts
Forward P/E—
Trailing P/E-1.7x
Forward PEG—
Implied Growth+65.1%
Median Target$7.00
Analyst Spread0.0%

Analysts see +55.9% upside to their consensus target of $7.00. The bullish rating consensus aligns with positive price target gap.

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$4.49
Consensus$7.00
High$7.00
Low$7.00
Bear Case
$7
+55.9%
Consensus
$7
+55.9%
Bull Case
$7
+55.9%

Analyst Ratings Distribution

Breakdown of 23 published analyst recommendations for CAMP

35% hold / mixed conviction
+28
BearishBullish
Weighted analyst sentiment score based on 23 ratings
ConsensusBuy
Coverage23 Analysts
Net Score+28
Bull / Bear61% / 4%
Strong Buy00%
Buy1461%
Hold835%
Sell14%
Strong Sell00%
Strong Buy
00%
Buy
1461%
Hold
835%
Sell
14%
Strong Sell
00%
Recommendation Mix61% Buy · 35% Hold · 4% Sell
Buy (14)Hold (8)Sell (1)

CAMP Price Target Analysis

Updated March 2, 2026

As of March 2, 2026, CAMP4 Therapeutics Corporation (CAMP) has a Wall Street consensus price target of $7.00, based on estimates from 23 covering analysts. With the stock currently trading at $4.49, this represents a potential upside of +55.9%. The company has a market capitalization of $210M.

Analyst price targets range from a low of $7.00 to a high of $7.00, representing a 0% spread in expectations. The median target of $7.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.

The current analyst consensus rating is Buy, with 14 analysts rating the stock as a Buy or Strong Buy,8 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.

From a valuation perspective, CAMP trades at a trailing P/E of -1.7x. Analysts expect EPS to grow +65.1% over the next year.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside+80.1%
Avg Forward P/E49.0x
Peers with Coverage10 / 10
CompanyMarket CapPriceTargetUpsideRatingFwd P/EAnalysts
ALNYAlnylam Pharmaceuticals, Inc.$44.1B$332.92$461.06+38.5%Buy49.0x51
IONSIonis Pharmaceuticals, Inc.$13.3B$81.15$89.13+9.8%Buy—32
ARWRArrowhead Pharmaceuticals, Inc.$8.7B$63.27$78.78+24.5%Buy—20
CRSPCRISPR Therapeutics AG$5.6B$60.14$65.00+8.1%Buy—38
BEAMBeam Therapeutics Inc.$2.9B$28.46$40.86+43.6%Buy—27
WVEWave Life Sciences Ltd.$2.2B$13.93$32.00+129.7%Buy—24
RNAAvidity Biosciences, Inc.$2.2B$14.75$74.67+406.2%Buy—20
STOKStoke Therapeutics, Inc.$2.0B$36.41$42.75+17.4%Buy—15
NTLAIntellia Therapeutics, Inc.$1.6B$13.78$19.38+40.6%Buy—38
ABUSArbutus Biopharma Corporation$895M$4.66$8.50+82.4%Buy—10

Upside Potential Comparison

RNA
+406.2%
WVE
+129.7%
ABUS
+82.4%
BEAM
+43.6%
NTLA
+40.6%
ALNY
+38.5%
ARWR
+24.5%
STOK
+17.4%

See CAMP's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is CAMP Undervalued?

See our Bear / Base / Bull DCF models and intrinsic value estimates.

View Valuation

Compare CAMP vs AGIO

See how CAMP stacks up against sector leader Agios Pharmaceuticals, Inc..

Start Comparison

Frequently Asked Questions

What is the CAMP stock price target for 2026?

The consensus Wall Street price target for CAMP is $7, representing 55.9% upside from the current price of $4.49. With 23 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

Is CAMP a buy, sell, or hold?

CAMP has a consensus rating of "Buy" based on 23 Wall Street analysts. The rating breakdown is predominantly bullish, with 14 Buy/Strong Buy ratings. The consensus 12-month price target of $7 implies 55.9% upside from current levels.

Is CAMP stock overvalued or undervalued?

CAMP's current price is $4.49 with a consensus target of $7 (55.9% implied move). Analyst estimates suggest the stock is undervalued at current levels.

How high can CAMP stock go?

The most bullish Wall Street analyst has a price target of $7 for CAMP, while the most conservative target is $7. The consensus of $7 represents the median expectation. These targets typically reflect 12-month expectations.

How many analysts cover CAMP stock?

CAMP is well covered by analysts, with 23 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 14 have Buy ratings, 8 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the CAMP stock forecast?

The 12-month CAMP stock forecast based on 23 Wall Street analysts shows a consensus price target of $7, with estimates ranging from $7 (bear case) to $7 (bull case). The median consensus rating is "Buy".

Should I buy CAMP stock?

Wall Street analysts are very optimistic on CAMP, with a "Buy" consensus rating and $7 price target (55.9% upside). 14 of 23 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do CAMP price targets vary so much?

CAMP analyst price targets range from $7 to $7, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $7 consensus represents the middle ground.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.